Promoting Use of Effective Early Intervention Programs

描述（由申请人提供）：现在有强有力的科学支持广泛实施经过验证的、有效的早期干预计划，用于患有或有发育障碍风险的幼儿。然而，在实践中，缺乏证明有效性的方案往往得到实施，削弱了早期干预的影响。当前项目的长期目标是提高0-5岁患有或有发育性残疾风险的儿童接受有效干预服务的可能性。为此目的，拟议的第二阶段工作的具体目标将是充分开发和准备商业传播三种产品，这些产品的原型已经存在于第一阶段完成的研发和先前成功的社会计量学产品中。中心产品是减少发育障碍早期干预项目档案（EIPARDD），它将包括所有必要材料（如手册、练习册）的完整复制包，以实施和评估经验支持的干预措施。在第一阶段，通过全面的科学文献检索和独立专家小组的广泛评估，确定了EIPARDD中包括的干预措施。在第一阶段，获得了12个经验支持的干预计划的访问权，并构建了一个EIPARDD计划的原型工具包，并得到了消费者的好评。第二阶段的具体目标是使EIPARDD中每个项目的所有材料在赠款期结束时准备好进行商业分发。其他两个产品通过以下方式增强了EIPARDD的使用：(1)通过在线早期干预计划选择资源，促进对特定需求（包括那些不能作为复制工具包提供的干预计划）的适当经验支持的干预计划的选择；(2)通过一套早期干预计划实施和评估教程，提供在线和USB闪存驱动器格式的通用和计划定制的实施和评估信息，促进计划的保真度和评估。第二阶段的具体目标是使这两种辅助产品在资助期结束时准备好进行商业分销。技术可用性测试和消费者反馈将在整个过程中广泛使用，以确保所有最终产品满足早期干预专业人员的需求。此外，将进行一项混合方法研究，以调查在新地点实施有效的早期干预计划的保真度。复制包将向地方、州和区域各级的早期干预决策者销售。这些产品的商业市场是巨大的，有超过102,000名专业人员根据联邦残疾人教育法（IDEA） B部分和C部分从事早期干预工作，为近100万名0-5岁的儿童提供服务。公共卫生相关性：EIPARDD及其相关产品将从两个关键方面促进公共卫生。它将:(1)为更多有发育迟缓或有发育迟缓风险的幼儿及其家庭提供有效的早期干预服务，为EI决策者提供一系列有效的EI项目，以便他们在提供EI服务时轻松、经济地选择、实施、适应和评估他们的努力；(2)为现有的和有抱负的EI专家提供有效的EI项目，为有发育迟缓或有发育迟缓风险的儿童提供早期儿童教师和培训师可访问的交互式研究信息，用于职前准备、员工入职培训和员工培训。结果应该是更广泛地使用、适应和评估对有发育迟缓或有发育迟缓风险的儿童有效的EI项目，以及更多高技能的EI专业人员。

DESCRIPTION (provided by applicant): There is now strong scientific support for the widespread implementation of proven, effective early intervention programs for young children with, or at risk for, developmental disability. However, in practice, programs that lack demonstrated effectiveness are often implemented, undermining the impact of early intervention. The long-term goal of the current project is to increase the likelihood that children ages 0-5 years with or at risk for developmental disability receive effective intervention services. To this end, the specific aims of the proposed Phase II work will be to fully develop and make ready for commercial dissemination three products for which prototypes already exist from R&D completed in Phase I and from prior successful Sociometrics products. The central product is the Early Intervention Program Archive to Reduce Developmental Disability (EIPARDD), which will consist of complete replication kits of all necessary materials (e.g., manuals, workbooks) to implement and evaluate an empirically-supported intervention. Interventions included in EIPARDD were identified through a comprehensive scientific literature search and extensive evaluation by an independent Expert Panel in Phase I. Access to 12 empirically-supported intervention programs was secured in Phase I, and a prototype kit for one EIPARDD program was constructed and favorably evaluated by consumers. The specific aim for Phase II is to make all materials for each program in EIPARDD ready for commercial distribution by the end of the grant period. The other two products enhance the use of EIPARDD by (1) facilitating the selection of the appropriate empirically-supported intervention program for a given need (including those not available as replication kits), through an online Early Intervention Program Selection Resource; and (2) promoting program fidelity and evaluation through a set of Early Intervention Program Implementation and Evaluation Tutorials that offer generalized and program- tailored implementation and evaluation information in online and USB flash drive formats. Specific Phase II aims are to make these two ancillary products ready for commercial distribution by the end of the grant period. Technical usability testing and consumer feedback will be used extensively throughout the process to ensure that all final products meet the needs of early intervention professionals. In addition, a mixed-method research study will be conducted to investigate the fidelity of implementing effective early intervention programs in new sites. The replication kits will be marketed to early intervention decision-makers at local, state and regional levels. The commercial market for these products is substantial with over 102,000 professionals working in early intervention under the federal Individuals with Disabilities Education Act (IDEA) Parts B and C, serving nearly one million children ages 0-5 years. PUBLIC HEALTH RELEVANCE: The EIPARDD and its associated products will promote public health in two key ways. It will: (1) offer more young children with or at risk of developmental delay and their families efficacious early intervention services, by providing EI decision-makers with an array of efficacious EI programs from which to easily and affordably select, implement, adapt, and evaluate their efforts as they deliver EI services, and (2) prepare current and aspiring EI specialists about effective EI programs for children with or at risk of developmental delays by offering early childhood faculty and trainers accessible and interactive research-based information for use in pre-service preparation, staff orientation, staff training. More widespread use, adaptation, and evaluation of efficacious EI programs for children with or at risk for developmental delay, and more highly skilled EI professionals, should be the result.